SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Heather A. Berlin, Ashley Braun, Daphne Simeon, Lorrin M. Koran, Marc N. Potenza, Susan L. McElroy, Timothy Fong, Stefano Pallanti, Eric Hollander, A double-blind, placebo-controlled trial of topiramate for pathological gambling, The World Journal of Biological Psychiatry, 2013, 14, 2, 121

    CrossRef

  2. 2
    María Reinares, Adriane R. Rosa, Carolina Franco, José Manuel Goikolea, Kostas Fountoulakis, Melina Siamouli, Xenia Gonda, Sophia Frangou, Eduard Vieta, A systematic review on the role of anticonvulsants in the treatment of acute bipolar depression, The International Journal of Neuropsychopharmacology, 2013, 16, 02, 485

    CrossRef

  3. 3
    Susan L. McElroy, Paul E. Keck, Obesity in Bipolar Disorder: An Overview, Current Psychiatry Reports, 2012, 14, 6, 650

    CrossRef

  4. 4
    Jeffrey J. DeVido, Roger D. Weiss, Treatment of the Depressed Alcoholic Patient, Current Psychiatry Reports, 2012, 14, 6, 610

    CrossRef

  5. 5
    Alessandra M.A. Nivoli, Francesc Colom, Andrea Murru, Isabella Pacchiarotti, Piero Castro-Loli, Ana González-Pinto, Kostas N. Fountoulakis, Eduard Vieta, New treatment guidelines for acute bipolar depression: A systematic review, Journal of Affective Disorders, 2011, 129, 1-3, 14

    CrossRef

  6. 6
    Arash Mowla, Ehsan Kardeh, Topiramate augmentation in patients with resistant major depressive disorder: A double-blind placebo-controlled clinical trial, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2011, 35, 4, 970

    CrossRef

  7. 7
    John W. Winkelman, Erin A. Johnson, Lisa M. Richards, Sleep Disorders, 2011,

    CrossRef

  8. 8
    Lindsey I Sinclair, Peter T Dineen, Andrea L Malizia, Modulation of ion channels in clinical psychopharmacology: adults and younger people, Expert Review of Clinical Pharmacology, 2010, 3, 3, 397

    CrossRef

  9. 9
    Arash Ansari, David N. Osser, The Psychopharmacology Algorithm Project at the Harvard South Shore Program, Harvard Review of Psychiatry, 2010, 18, 1, 36

    CrossRef

  10. 10
    Vivek Datta, Anthony J Cleare, Recent advances in bipolar disorder pharmacotherapy: focus on bipolar depression and rapid cycling, Expert Review of Clinical Pharmacology, 2009, 2, 4, 423

    CrossRef

  11. 11
    Andrea H. Weinberger, Jennifer C. Vessicchio, Kristi A. Sacco, Cerissa L. Creeden, K.N. Roy Chengappa, Tony P. George, A Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Disorder, Journal of Clinical Psychopharmacology, 2008, 28, 5, 584

    CrossRef

  12. 12
    Thomas H. Loew, Marius K. Nickel, Topiramate Treatment of Women With Borderline Personality Disorder, Part II, Journal of Clinical Psychopharmacology, 2008, 28, 3, 355

    CrossRef

  13. 13
    Robert M. Post, Antiepileptic Drugs to Treat Psychiatric Disorders, 2008,

    CrossRef

  14. 14
    Erik Nelson, Antiepileptic Drugs to Treat Psychiatric Disorders, 2008,

    CrossRef

  15. 15
    Susan L. McElroy, Anna I. Guerdjikova, Paul E. Keck, Harrison G. Pope, James I. Hudson, Antiepileptic Drugs to Treat Psychiatric Disorders, 2008,

    CrossRef

  16. 16
    Susan L McElroy, Mark A Frye, Lori L Altshuler, Trisha Suppes, Gerhard Hellemann, David Black, Jim Mintz, Ralph Kupka, Willem Nolen, Gabriele S Leverich, Kirk D Denicoff, Robert M Post, Paul E Keck, A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders, Bipolar Disorders, 2007, 9, 4
  17. 17
    Adel Gabriel, Adjunctive topiramate treatment in refractory obese bipolar patients: A descriptive open label study, Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 2007, 12, 1, 48

    CrossRef

  18. 18
    Paul J Goodnick, Bipolar depression: a review of randomised clinical trials, Expert Opinion on Pharmacotherapy, 2007, 8, 1, 13

    CrossRef

  19. 19
    E. Okuyucu, İ. M. Melek, T. Duman, T. Tunç, Hypomania complicating topiramate therapy for migraine prophylaxis, European Journal of Neurology, 2007, 14, 3
  20. 20
    Barbara R Sommer, Howard H Fenn, Terence A Ketter, Safety and efficacy of anticonvulsants in elderly patients with psychiatric disorders: oxcarbazepine, topiramate and gabapentin, Expert Opinion on Drug Safety, 2007, 6, 2, 133

    CrossRef

  21. 21
    Garth A. Hargreaves, Iain S. McGregor, Topiramate Moderately Reduces the Motivation to Consume Alcohol and Has a Marked Antidepressant Effect in Rats, Alcoholism: Clinical and Experimental Research, 2007, 31, 11
  22. 22
    Sara Poston, Michael Dickson, Michael Johnsrud, Marcia F.T. Rupnow, Joette M. Gdovin, Thomas J. Bramley, Robert B. Armstrong, Topiramate prescribing patterns among medicaid patients: Diagnosis, comorbidities, and dosing, Clinical Therapeutics, 2007, 29, 3, 504

    CrossRef

  23. 23
    David E. Kemp, Keming Gao, David J. Muzina, Prashant Gajwani, Joseph R. Calabrese, Trial-Based Advances in the Treatment of Bipolar Depression, Progress in Neurotherapeutics and Neuropsychopharmacology, 2007, 2, 193

    CrossRef

  24. 24
    Alan B. Ettinger, Charles E. Argoff, Use of antiepileptic drugs for nonepileptic conditions: Psychiatric disorders and chronic pain, Neurotherapeutics, 2007, 4, 1, 75

    CrossRef

  25. 25
    Sherif Karama, Samarthji Lal, Adjunctive topiramate in ultradian cycling bipolar disorder: case report with 3-year follow-up, European Psychiatry, 2006, 21, 4, 280

    CrossRef

  26. 26
    MICHAEL E. THASE, Bipolar depression: Diagnostic and treatment considerations, Development and Psychopathology, 2006, 18, 04

    CrossRef

  27. You have free access to this content27
    Lakshmi N Yatham, Sidney H Kennedy, Claire O'Donovan, Sagar V Parikh, Glenda MacQueen, Roger S McIntyre, Verinder Sharma, Serge Beaulieu, Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007, Bipolar Disorders, 2006, 8, 6
  28. 28
    Susan L McElroy, Renu Kotwal, Paul E Keck, Comorbidity of eating disorders with bipolar disorder and treatment implications, Bipolar Disorders, 2006, 8, 6
  29. 29
    Jessica L. Gören, Hyperthyroidism Associated With Topiramate Treatment, Psychosomatics, 2006, 47, 6, 529

    CrossRef

  30. 30
    Renu Kotwal, Anna Guerdjikova, Susan L. McElroy, Paul E. Keck, Lithium augmentation of topiramate for bipolar disorder with comorbid binge eating disorder and obesity, Human Psychopharmacology: Clinical and Experimental, 2006, 21, 7
  31. 31
    Michael E. Thase, Pharmacotherapy of bipolar depression: An update, Current Psychiatry Reports, 2006, 8, 6, 478

    CrossRef

  32. 32
    Marco Mula, Andrea E Cavanna, Francesco Monaco, Psychopharmacology of topiramate: from epilepsy to bipolar disorder, Neuropsychiatric Disease and Treatment, 2006, 2, 4, 475

    CrossRef

  33. 33
    Lanju Zhang, William F. Rosenberger, Response-Adaptive Randomization for Clinical Trials with Continuous Outcomes, Biometrics, 2006, 62, 2
  34. You have free access to this content34
    Stuart F Kushner, Akbar Khan, Rosanne Lane, William H Olson, Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials, Bipolar Disorders, 2006, 8, 1
  35. 35
    Thomas H. Loew, Marius K. Nickel, Moritz Muehlbacher, Patrick Kaplan, Cerstin Nickel, Christian Kettler, Rainhold Fartacek, Claas Lahmann, Wiebke Buschmann, Karin Tritt, Egon Bachler, Ferdinand Mitterlehner, Francisco Pedrosa Gil, Peter Leiberich, Wolfhardt K. Rother, Christoph Egger, Topiramate Treatment for Women With Borderline Personality Disorder, Journal of Clinical Psychopharmacology, 2006, 26, 1, 61

    CrossRef

  36. 36
    J. Thuile, C. Even, J.D. Guelfi, Traitement pharmacologique des dépressions bipolaires, L'Encéphale, 2006, 32, 5, 767

    CrossRef

  37. 37
    M Gitlin, Treatment-resistant bipolar disorder, Molecular Psychiatry, 2006, 11, 3, 227

    CrossRef

  38. 38
    Xavier Castells, Antoni Vallano, David Rigau, Joselin Pérez, Miguel Casas, Dolors Capellà, Trends in lithium prescription in Spain from 1985 to 2003, Journal of Affective Disorders, 2006, 91, 2-3, 273

    CrossRef

  39. 39
    Roger S. McIntyre, Jakub Z. Konarski, Paul E. Keck, Obesity and Mental Disorders, 2006,

    CrossRef

  40. 40
    Susan L. McElroy, Renu Kotwal, Erik B Nelson, Shishuka Malhotra, Paul E Keck, Charles B Nemeroff, Obesity and Mental Disorders, 2006,

    CrossRef

  41. 41
    Susan L. McElroy, Renu Kotwal, Paul E. Keck, Obesity and Mental Disorders, 2006,

    CrossRef

  42. 42
    Robert M Post, Adjunctive strategies in the treatment of refractory bipolar depression: clinician options in the absence of a systematic database, Expert Opinion on Pharmacotherapy, 2005, 6, 4, 531

    CrossRef

  43. 43
    Vivek Singh, David J. Muzina, Joseph R. Calabrese, Anticonvulsants in Bipolar Disorder, Psychiatric Clinics of North America, 2005, 28, 2, 301

    CrossRef

  44. 44
    Michael E. Thase, Bipolar Depression: Issues in Diagnosis and Treatment, Harvard Review of Psychiatry, 2005, 13, 5, 257

    CrossRef

  45. 45
    Lakshmi N Yatham, Sidney H Kennedy, Claire O'Donovan, Sagar Parikh, Glenda MacQueen, Roger McIntyre, Verinder Sharma, Peter Silverstone, Martin Alda, Philippe Baruch, Serge Beaulieu, Andree Daigneault, Roumen Milev, L. Trevor Young, Arun Ravindran, Ayal Schaffer, Mary Connolly, Chris P Gorman, Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies, Bipolar Disorders, 2005, 7,
  46. 46
    Susan L. McElroy, Renu Kotwal, Paul E. Keck, Hagop S. Akiskal, Comorbidity of bipolar and eating disorders: distinct or related disorders with shared dysregulations?, Journal of Affective Disorders, 2005, 86, 2-3, 107

    CrossRef

  47. 47
    Marcia Kaplan, Hypomania With Topiramate, Journal of Clinical Psychopharmacology, 2005, 25, 2, 196

    CrossRef

  48. 48
    Zubin Bhagwagar, Guy M Goodwin, Lamotrigine in the treatment of bipolar disorder, Expert Opinion on Pharmacotherapy, 2005, 6, 8, 1401

    CrossRef

  49. 49
    Keming Gao, Joseph R Calabrese, Newer treatment studies for bipolar depression, Bipolar Disorders, 2005, 7,
  50. 50
    Bankole A Johnson, Recent Advances in the Development of Treatments for Alcohol and Cocaine Dependence, CNS Drugs, 2005, 19, 10, 873

    CrossRef

  51. 51
    Deborah Antai-Otong, The Art of Prescribing, Perspectives in Psychiatric Care, 2005, 41, 2
  52. 52
    Sandra Ghelardoni, Richard P. Bazinet, Stanley I. Rapoport, Francesca Bosetti, Topiramate does not alter expression in rat brain of enzymes of arachidonic acid metabolism, Psychopharmacology, 2005, 180, 3, 523

    CrossRef

  53. 53
    Cerstin Nickel, Claas Lahmann, Karin Tritt, Moritz Muehlbacher, Patrick Kaplan, Christian Kettler, Jakub Krawczyk, Thomas H. Loew, Wolfhardt K. Rother, Marius K. Nickel, Topiramate in treatment of depressive and anger symptoms in female depressive patients: A randomized, double-blind, placebo-controlled study, Journal of Affective Disorders, 2005, 87, 2-3, 243

    CrossRef

  54. 54
    Steven L. Dubovsky, Treatment of Bipolar Depression, Psychiatric Clinics of North America, 2005, 28, 2, 349

    CrossRef

  55. 55
    Peter H. Silverstone, Trevor Silverstone, A review of acute treatments for bipolar depression, International Clinical Psychopharmacology, 2004, 19, 3, 113

    CrossRef

  56. 56
    Frank MC Besag, Behavioural effects of the newer antiepileptic drugs: an update, Expert Opinion on Drug Safety, 2004, 3, 1, 1

    CrossRef

  57. 57
    Deborah Antai-Otong, Bipolar II or Unipolar Depression: Pharmacologic Considerations, Perspectives in Psychiatric Care, 2004, 40, 3
  58. 58
    Robert M. Post, Differing psychotropic profiles of the anticonvulsants in bipolar and other psychiatric disorders, Clinical Neuroscience Research, 2004, 4, 1-2, 9

    CrossRef

  59. 59
    Eduard Vieta, Jose S??nchez-Moreno, Jos?? Manuel Goikolea, Francesc Colom, Anabel Mart??nez-Ar??n, Antonio Benabarre, B??rbara Corbella, Carla Torrent, Merc?? Comes, Mar??a Reinares, Esteve Brugue, Effects on Weight and Outcome of Long-term Olanzapine-Topiramate Combination Treatment in Bipolar Disorder, Journal of Clinical Psychopharmacology, 2004, 24, 4, 374

    CrossRef

  60. 60
    Eric H. Kossoff, Paula L. Pyzik, Improvement in alertness and behavior in children treated with combination topiramate and vagus nerve stimulation, Epilepsy & Behavior, 2004, 5, 2, 256

    CrossRef

  61. 61
    T. A. Ketter, P. W. Wang, C. Nowakowska, W. K. Marsh, New medication treatment options for bipolar disorders, Acta Psychiatrica Scandinavica, 2004, 110,
  62. 62
    Eduard Vieta, José Sánchez-Moreno, José M Goikolea, Carla Torrent, Antoni Benabarre, Francesc Colom, Anabel Martínez-Arán, María Reinares, Mercè Comes, Barbara Corbella, Adjunctive topiramate in bipolar II disorder, World Journal of Biological Psychiatry, 2003, 4, 4, 172

    CrossRef

  63. 63
    Carrie L. Ernst, Joseph F. Goldberg, Antidepressant Properties of Anticonvulsant Drugs for Bipolar Disorder, Journal of Clinical Psychopharmacology, 2003, 23, 2, 182

    CrossRef

  64. 64
    Lakshmi N Yatham, Joseph R Calabrese, Vivek Kusumakar, Bipolar depression: criteria for treatment selection, definition of refractoriness, and treatment options, Bipolar Disorders, 2003, 5, 2
  65. 65
    Barry E Gidal, Raj D Sheth, Leslie Magnus, Anne-Francoise Herbeuval, Levetiracetam does not alter body weight: analysis of randomized, controlled clinical trials, Epilepsy Research, 2003, 56, 2-3, 121

    CrossRef

  66. 66
    Michael Berk, Seetal Dodd, Recent developments in the treatment of bipolar disorders, Expert Opinion on Investigational Drugs, 2003, 12, 10, 1621

    CrossRef

  67. 67
    Pierre Chue, Christopher S Kovacs, Safety and tolerability of atypical antipsychotics in patients with bipolar disorder: prevalence, monitoring and management, Bipolar Disorders, 2003, 5,
  68. 68
    Michael V Miles, Peter H Tang, Tracy A Glauser, Melody A Ryan, Shellee A Grim, Richard H Strawsburg, Ton J deGrauw, Robert J Baumann, Topiramate concentration in saliva: an alternative to serum monitoring, Pediatric Neurology, 2003, 29, 2, 143

    CrossRef

  69. 69
    Michael E Thase, Manoj Bhargava, Gary S Sachs, Treatment of bipolar depression: current status, continued challenges, and the STEP-BD approach, Psychiatric Clinics of North America, 2003, 26, 2, 495

    CrossRef

  70. 70
    John W. Winkelman, Treatment of nocturnal eating syndrome and sleep-related eating disorder with topiramate, Sleep Medicine, 2003, 4, 3, 243

    CrossRef

  71. 71
    JOSEPH F. GOLDBERG, When Do Antidepressants Worsen the Course of Bipolar Disorder?, Journal of Psychiatric Practice, 2003, 9, 3, 181

    CrossRef

  72. 72
    Robert M Post, Andrew M Speer, Gabriela V Obrocea, Gabriele S Leverich, Acute and prophylactic effects of anticonvulsants in bipolar depression, Clinical Neuroscience Research, 2002, 2, 3-4, 228

    CrossRef

  73. You have free access to this content73
    Current Awareness in Human Psychopharmacology, Human Psychopharmacology: Clinical and Experimental, 2002, 17, 7
  74. 74
    Michael E Thase, Gary S Sachs, The challenges of pharmacotherapy of bipolar depression, Clinical Neuroscience Research, 2002, 2, 3-4, 213

    CrossRef

  75. 75
    Terence A Ketter, Po W Wang, Suttiporn Janenawasin, Olga V Becker, Adrian Wang, The Emerging Role of Olanzapine in Bipolar Disorders, Psychiatric Annals, 2002, 32, 12, 753

    CrossRef

  76. 76
    Bipolar Disorder, Wiley Handbook of Current and Emerging Drug Therapies,
  77. 77
    Heinz Grunze, Carbamazepine and Other Anticonvulsants,
  78. 78
    Michael S. Saporito, Christopher A. Lipinski, Andrew G. Reaume, Phenotypic In Vivo Screening to Identify New, Unpredicted Indications for Existing Drugs and Drug Candidates,
  79. 79
    Alan C. Swann, Practical Pharmacological Maintenance Treatment of Bipolar Disorder,
  80. 80
    Kamini Vasudev, Karine Macritchie, John Geddes, Stuart Watson, Allan H Young, Topiramate for acute affective episodes in bipolar disorder, The Cochrane Library,